Olga V. Zhigunova
Olga V. Zhigunova has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Denis S. Vorobyev
I.I. Mechnikov Research Institute of Vaccines and Sera
5 shared publications - Irina M. Gruber
Federal State Budget Institution of Science « Mechnikov Research Institute of Vaccines and Sera
4 shared publications - O. M. Afanasyeva
Federal State Budget Institution of Science « Mechnikov Research Institute of Vaccines and Sera
4 shared publications - Natalia E. Yastrebova
I.I. Mechnikov Research Institute of Vaccines and Sera
3 shared publications - Anna Yu. Leonova
I.I. Mechnikov Research Institute of Vaccines and Sera
2 shared publications - E. S. Petukhova
I.I. Mechnikov Research Institute of Vaccines and Sera
2 shared publications
Latest Publications
- Open Access
- 15 July 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (2) , 72-80
Immunobiological properties of a mixture of antigens from experimental protective protein-containing fractions isolated by different methods from the Streptococcus oralis strain
Background. Previously, the main pathogenicity factors of closely related strains of Mitis group streptococci of different virulence, including Streptococcus pneumoniae and Streptococcus oralis, were determined. Differences in the protein composition of protein-containing fractions (PCF) with a molecular weight of 30–100 kDa isolated from them using Amicon®Ultra filters (Millipore, Ireland) were established. It was of interest to obtain PCF by gel filtration (PCF-C) and the determination of the possibility of its use in the development of an antipneumococcal drug. Aim. Comparison of the immunobiological properties of PCF from the S. oralis strain isolated by different methods and a study of the protective activity of a mixture of antigens of the Mitis group of streptococci. Materials and methods. PCF-C was prepared by exclusion chromatography on a Toyopearl HW-55 column. Surface protein-containing antigens of S. oralis were assessed by protein content using the Lowry method and electrophoretic characteristics using the Laemmli method. The protective activity was studied in experiments on active protection of BALB / c mice with two intraperitoneal injections (with an interval of 14 days) of three preparations: PCF and PCF-C (50 μg protein / mouse) and a mixture of PCF-C + recombinant atoxic pneumolysin (raPly) (25 μg protein / mouse). Immunized mice were intranasally infected with a virulent strain of S. pneumoniae serotype 3 No. 10196. The level of specific immunoglobulin G (IgG) antibodies was determined in the hyperimmune sera of mice using solid-phase enzyme-linked immunosorbent assay. Statistical processing of the results was performed using parametric and nonparametric comparison methods. Results. A comparative analysis of the PCF-C and PCF series established their protective activity against the virulent strain of S. pneumoniae; both preparations induced the production of specific IgG antibodies, did not differ in protein yield and were non-toxic. The protective activity of the PCF-C + raPly mixture was established. Conclusion. The feasibility of using a surface protein-containing antigen of S. oralis obtained using size-exclusion chromatography, including as part of a two-component experimental preparation in a mixture with raPly not sorbed on aluminum hydroxide, is demonstrated.
- 15 July 2026
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 25 (2) , 72-80
Open AccessImmunobiological properties of a mixture of antigens from experimental protective protein-containing fractions isolated by different methods from the Streptococcus oralis strain
Background. Previously, the main pathogenicity factors of closely related strains of Mitis group streptococci of different virulence, including Streptococcus pneumoniae and Streptococcus oralis, were determined. Differences in the protein composition of protein-containing fractions (PCF) with a molecular weight of 30–100 kDa isolated from them using Amicon®Ultra filters (Millipore, Ireland) were established. It was of interest to obtain PCF by gel filtration (PCF-C) and the determination of the possibility of its use in the development of an antipneumococcal drug. Aim. Comparison of the immunobiological properties of PCF from the S. oralis strain isolated by different methods and a study of the protective activity of a mixture of antigens of the Mitis group of streptococci. Materials and methods. PCF-C was prepared by exclusion chromatography on a Toyopearl HW-55 column. Surface protein-containing antigens of S. oralis were assessed by protein content using the Lowry method and electrophoretic characteristics using the Laemmli method. The protective activity was studied in experiments on active protection of BALB / c mice with two intraperitoneal injections (with an interval of 14 days) of three preparations: PCF and PCF-C (50 μg protein / mouse) and a mixture of PCF-C + recombinant atoxic pneumolysin (raPly) (25 μg protein / mouse). Immunized mice were intranasally infected with a virulent strain of S. pneumoniae serotype 3 No. 10196. The level of specific immunoglobulin G (IgG) antibodies was determined in the hyperimmune sera of mice using solid-phase enzyme-linked immunosorbent assay. Statistical processing of the results was performed using parametric and nonparametric comparison methods. Results. A comparative analysis of the PCF-C and PCF series established their protective activity against the virulent strain of S. pneumoniae; both preparations induced the production of specific IgG antibodies, did not differ in protein yield and were non-toxic. The protective activity of the PCF-C + raPly mixture was established. Conclusion. The feasibility of using a surface protein-containing antigen of S. oralis obtained using size-exclusion chromatography, including as part of a two-component experimental preparation in a mixture with raPly not sorbed on aluminum hydroxide, is demonstrated.
- Open Access
- 13 March 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (1) , 99-110
Molecular biological characteristics of Mitis group streptococci
Relevance. Mitis Group Streptococci (SMG), which belong to one of the 5 groups of greening streptococci, are a component of the normal human nasopharyngeal flora and include 17 known species. Among SMG, Streptococcus pneumoniae is the most common cause of a number of invasive and non-invasive human diseases that lead to high mortality rates worldwide. It is interesting to note that a number of studies have shown not only differences, but also similarities in the genes encoding the pathogenicity factors of S. pneumoniae and other members of the SMG, particularly Streptococcus oralis. Aims. To analyze and summarize the results of molecular genetic studies of the SMG and identify the features of the genetic diversity of the pathogen strains. Conclusion. The comparative analysis of the genomes of closely related SMG species revealed key common genes encoding the main pathogenicity factors, which allows for the optimization of the selection of candidate strains for development.
- 13 March 2026
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 25 (1) , 99-110
Open AccessMolecular biological characteristics of Mitis group streptococci
Relevance. Mitis Group Streptococci (SMG), which belong to one of the 5 groups of greening streptococci, are a component of the normal human nasopharyngeal flora and include 17 known species. Among SMG, Streptococcus pneumoniae is the most common cause of a number of invasive and non-invasive human diseases that lead to high mortality rates worldwide. It is interesting to note that a number of studies have shown not only differences, but also similarities in the genes encoding the pathogenicity factors of S. pneumoniae and other members of the SMG, particularly Streptococcus oralis. Aims. To analyze and summarize the results of molecular genetic studies of the SMG and identify the features of the genetic diversity of the pathogen strains. Conclusion. The comparative analysis of the genomes of closely related SMG species revealed key common genes encoding the main pathogenicity factors, which allows for the optimization of the selection of candidate strains for development.
- Open Access
- 3 May 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (2) , 24-32
Comparative analysis of pathogenicity factors of closely related Mitis group streptococci and surface protein-containing antigens isolated from them
Relevance. Mitis group streptococci (SMG) include 9 species of streptococci most frequently isolated from patients, including Streptococcus oralis and Streptococcus pneumoniae. The study of SMG shows not only differences but also overlaps in the genes encoding pathogenicity factors of S. pneumoniae and S. oralis. Earlier it was shown that antigens from S. pneumoniae serotype 6B induced cross-protective effect against virulent strains of S. pneumoniae. It was found that the experimental surface protein-containing fraction with molecular weight 30-100 kDa (PCF) from S. oralis has protective activity, stimulates in mice indicators of innate and adaptive immunity.Objective: to carry out a comparative analysis of pathogenicity factors of S. oralis and S. pneumoniae strains and protective activity of surface protein-containing antigens isolated from them.Materials and methods. The strains of S. oralis and S. pneumoniae serotype 6B Nos. 3353 and 1121 of different virulence were used. Experimental protein-containing antigens, in particular, PCF, were prepared from these strains. The protective activity of the obtained PCFs was evaluated in active protection experiments during intraperitoneal immunization and infection of BALB/c mice. Mass spectrometric study of PCF was carried out using UniProtKB database, taxon S. pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4.) Statistical processing of the results was carried out using parametric and nonparametric methods of comparison (pResults and discussion. PCF from S. oralis has cross-species protective activity against virulent strains of S. pneumoniae of different serotypes, while PCF from S. pneumoniae strain 6B No. 3353 protects only against a virulent strain of the homologous serotype. Comparative analysis of genes encoding pathogenicity factors revealed differences: only in S. oralis genes encoding the synthesis of proteins promoting adhesion and biofilm formation (SspA, GtfD RlrA), and in S. pneumoniae strains - pore-forming toxin (Ply) and choline-binding protein (LytA) were identified. In the proteomic analysis of S. oralis and S. pneumoniae 6B No. 3353 PCFs, out of 673 identified proteins, 57 common proteins of most interest and 21 and 35 unique proteins, respectively, were selected for each PCF: in S. oralis PCFs, adhesion proteins were identified, as well as proteins related to metabolic systems and mediating the development of the infection process, while in S. pneumoniae PCFs, adhesion proteins were predominant those indirectly involved in the development of the infectious process, while the S. pneumoniae PCF is dominated by proteins related to the main pathogenicity factors.Conclusions. The surface protein-containing fraction 30 -100 kDa (PCF) isolated from a weakly virulent strain of S. oralis, belonging to the Mitis group streptococci, has interspecies protective activity against strains of closely related species - S. pneumoniae of different serotypes. PCF is capable of both preventing adhesion and colonization of pneumococcus and possibly playing the role of a natural adjuvant. In addition, it may be of interest to determine the protective effect of this antigen against other closely related SMG representatives. Both different and common genes encoding the synthesis of the main pneumococcal pathogenicity factors were identified in the strains, and unique proteins for each of them were determined by proteomic analysis of PCF.
- 3 May 2025
- Published by LLC Numicom in Epidemiology and Vaccinal Prevention
- Vol. 24 (2) , 24-32
Open AccessComparative analysis of pathogenicity factors of closely related Mitis group streptococci and surface protein-containing antigens isolated from them
Relevance. Mitis group streptococci (SMG) include 9 species of streptococci most frequently isolated from patients, including Streptococcus oralis and Streptococcus pneumoniae. The study of SMG shows not only differences but also overlaps in the genes encoding pathogenicity factors of S. pneumoniae and S. oralis. Earlier it was shown that antigens from S. pneumoniae serotype 6B induced cross-protective effect against virulent strains of S. pneumoniae. It was found that the experimental surface protein-containing fraction with molecular weight 30-100 kDa (PCF) from S. oralis has protective activity, stimulates in mice indicators of innate and adaptive immunity.Objective: to carry out a comparative analysis of pathogenicity factors of S. oralis and S. pneumoniae strains and protective activity of surface protein-containing antigens isolated from them.Materials and methods. The strains of S. oralis and S. pneumoniae serotype 6B Nos. 3353 and 1121 of different virulence were used. Experimental protein-containing antigens, in particular, PCF, were prepared from these strains. The protective activity of the obtained PCFs was evaluated in active protection experiments during intraperitoneal immunization and infection of BALB/c mice. Mass spectrometric study of PCF was carried out using UniProtKB database, taxon S. pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4.) Statistical processing of the results was carried out using parametric and nonparametric methods of comparison (pResults and discussion. PCF from S. oralis has cross-species protective activity against virulent strains of S. pneumoniae of different serotypes, while PCF from S. pneumoniae strain 6B No. 3353 protects only against a virulent strain of the homologous serotype. Comparative analysis of genes encoding pathogenicity factors revealed differences: only in S. oralis genes encoding the synthesis of proteins promoting adhesion and biofilm formation (SspA, GtfD RlrA), and in S. pneumoniae strains - pore-forming toxin (Ply) and choline-binding protein (LytA) were identified. In the proteomic analysis of S. oralis and S. pneumoniae 6B No. 3353 PCFs, out of 673 identified proteins, 57 common proteins of most interest and 21 and 35 unique proteins, respectively, were selected for each PCF: in S. oralis PCFs, adhesion proteins were identified, as well as proteins related to metabolic systems and mediating the development of the infection process, while in S. pneumoniae PCFs, adhesion proteins were predominant those indirectly involved in the development of the infectious process, while the S. pneumoniae PCF is dominated by proteins related to the main pathogenicity factors.Conclusions. The surface protein-containing fraction 30 -100 kDa (PCF) isolated from a weakly virulent strain of S. oralis, belonging to the Mitis group streptococci, has interspecies protective activity against strains of closely related species - S. pneumoniae of different serotypes. PCF is capable of both preventing adhesion and colonization of pneumococcus and possibly playing the role of a natural adjuvant. In addition, it may be of interest to determine the protective effect of this antigen against other closely related SMG representatives. Both different and common genes encoding the synthesis of the main pneumococcal pathogenicity factors were identified in the strains, and unique proteins for each of them were determined by proteomic analysis of PCF.
- Open Access
- 10 December 2022
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 21 (4) , 71-75
Serotype-independent protective activity of recombinant pneumolysin in a model of systemic infection caused by Streptococcus pneumoniae serotypes 4 and 6B
Background. The development of a pneumococcal vaccine with serotype-independent activity is relevant for the whole world, as this is due to the high prevalence of Streptococcus pneumoniae (S. pneumoniae), the constant change of pathogen serotypes and the growth of antibiotic-resistant strains. In previous experiments, we revealed a protective effect of immunization with recombinant pneumolysin (rPly) in a model of systemic infection caused by S. pneumoniae serotype 3.Aim. Study of serotype-independent protective activity of rPly.Materials and methods. Strains of S. pneumoniae serotypes 4 and 6B were used. Mice were immunized intraperi-toneally two or three times with an interval of 14 days with rPly. To assess the protective activity of rPly, animals after double or triple immunization were infected intraperitoneally with S. pneumoniae .Results. rPly at a triple immunization in a dose of 25 μg protected mice from intraperitoneal infection with S. pneu- moniae serotype 4, the efficiency index increased by 2 times compared with the control. with a double immunization, rPly protected mice from intraperitoneal infection with S. pneumoniae serotype 6B, efficiency index increased by 6.61 times compared with the control.Conclusion. rPly protects animals from infection with different serotypes of S. pneumoniae, which allows us to consider it a promising drug for the development of pneumococcal vaccines with serotype-independent activity.
- 10 December 2022
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 21 (4) , 71-75
Open AccessSerotype-independent protective activity of recombinant pneumolysin in a model of systemic infection caused by Streptococcus pneumoniae serotypes 4 and 6B
Background. The development of a pneumococcal vaccine with serotype-independent activity is relevant for the whole world, as this is due to the high prevalence of Streptococcus pneumoniae (S. pneumoniae), the constant change of pathogen serotypes and the growth of antibiotic-resistant strains. In previous experiments, we revealed a protective effect of immunization with recombinant pneumolysin (rPly) in a model of systemic infection caused by S. pneumoniae serotype 3.Aim. Study of serotype-independent protective activity of rPly.Materials and methods. Strains of S. pneumoniae serotypes 4 and 6B were used. Mice were immunized intraperi-toneally two or three times with an interval of 14 days with rPly. To assess the protective activity of rPly, animals after double or triple immunization were infected intraperitoneally with S. pneumoniae .Results. rPly at a triple immunization in a dose of 25 μg protected mice from intraperitoneal infection with S. pneu- moniae serotype 4, the efficiency index increased by 2 times compared with the control. with a double immunization, rPly protected mice from intraperitoneal infection with S. pneumoniae serotype 6B, efficiency index increased by 6.61 times compared with the control.Conclusion. rPly protects animals from infection with different serotypes of S. pneumoniae, which allows us to consider it a promising drug for the development of pneumococcal vaccines with serotype-independent activity.
- Open Access
- 3 December 2021
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 20 (4) , 59-65
Protective activity of mixtures of pneumococcal antigens in infection caused by Streptococcus pneumoniae serotype 3
Introduction. Pneumococcal diseases remain relevant for the whole world. On the one hand, this is due to the high prevalence of pneumococcus and the other hand, the growth of antibiotic-resistant strains and the constant change of clinically significant serotypes of the pathogen.The aim of the research was to study of the protective activity of a mixture of pneumococcal antigens.Material and methods. we used preparations of a capsular polysaccharide (CPS) obtained from Streptococcus pneumoniae serotype 3; protein-containing fraction (PCF) obtained from an aqueous extract of cells of S. pneumoniae serotype 6B; recombinant pneumolysin (rPly). Mice were immunized intraperitoneally twice with an interval of 14 days with mixtures of bacterial antigens: CPS + PCF; CPS + rPly; PCF + rPly. To assess the protective activity of the studied drugs after double immunization animals were infected intraperitoneally with S. pneumoniae serotype 3. To study the effect of mixtures of bacterial preparations on the infectious process in the lungs immunized mice were infected with S. pneumoniae serotype 3. The humoral immune response was studied with IgG using the method of ELISA.Results. The CPS + rPly mixture protected mice from intraperitoneal infection with S. pneumoniae serotype 3 regardless of the infecting dose. Immunization with CPS + PCF or CPS + rPly mixtures influenced a significant decrease the number of seeded bacterial cells from lungs during the entire observation period (72 h) compared to the control. Administration of mixtures of bacterial antigens of CPS + PCF, CPS + rPly or PCF + rPly to animals led to a significant increase of the level of antibodies to all antigens, however, the highest levels of IgG were determined to PCF and rPly.Conclusion. The results obtained suggest that different antigenic drugs in mixtures affect different mechanisms of immunity activation.
- 3 December 2021
- Published by Publishing House ABV Press in Russian Journal of Biotherapy
- Vol. 20 (4) , 59-65
Open AccessProtective activity of mixtures of pneumococcal antigens in infection caused by Streptococcus pneumoniae serotype 3
Introduction. Pneumococcal diseases remain relevant for the whole world. On the one hand, this is due to the high prevalence of pneumococcus and the other hand, the growth of antibiotic-resistant strains and the constant change of clinically significant serotypes of the pathogen.The aim of the research was to study of the protective activity of a mixture of pneumococcal antigens.Material and methods. we used preparations of a capsular polysaccharide (CPS) obtained from Streptococcus pneumoniae serotype 3; protein-containing fraction (PCF) obtained from an aqueous extract of cells of S. pneumoniae serotype 6B; recombinant pneumolysin (rPly). Mice were immunized intraperitoneally twice with an interval of 14 days with mixtures of bacterial antigens: CPS + PCF; CPS + rPly; PCF + rPly. To assess the protective activity of the studied drugs after double immunization animals were infected intraperitoneally with S. pneumoniae serotype 3. To study the effect of mixtures of bacterial preparations on the infectious process in the lungs immunized mice were infected with S. pneumoniae serotype 3. The humoral immune response was studied with IgG using the method of ELISA.Results. The CPS + rPly mixture protected mice from intraperitoneal infection with S. pneumoniae serotype 3 regardless of the infecting dose. Immunization with CPS + PCF or CPS + rPly mixtures influenced a significant decrease the number of seeded bacterial cells from lungs during the entire observation period (72 h) compared to the control. Administration of mixtures of bacterial antigens of CPS + PCF, CPS + rPly or PCF + rPly to animals led to a significant increase of the level of antibodies to all antigens, however, the highest levels of IgG were determined to PCF and rPly.Conclusion. The results obtained suggest that different antigenic drugs in mixtures affect different mechanisms of immunity activation.